We serve Chemical Name:4-ethynylbenzene-1,2-diol CAS:366808-04-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-ethynylbenzene-1,2-diol
CAS.NO:366808-04-0
Synonyms:4-ETHYNYL-2-HYDROXY-PHENOL;4-Ethynyl-1,2-Benzenediol
Molecular Formula:C8H6O2
Molecular Weight:134.13200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:288.807ºC at 760 mmHg
Density:1.315g/cm3
Index of Refraction:1.643
PSA:40.46000
Exact Mass:134.03700
LogP:1.07910
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-ETHYNYL-2-HYDROXY-PHENOL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Ethynyl-1,2-Benzenediol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethynyl-1,2-Benzenediol Use and application,4-Ethynyl-1,2-Benzenediol technical grade,usp/ep/jp grade.
Related News: In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 4-ethynylbenzene-1,2-diol manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 4-ethynylbenzene-1,2-diol supplier With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. 4-ethynylbenzene-1,2-diol vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 4-ethynylbenzene-1,2-diol factory With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.
